Keith S Pentlow

Keith S Pentlow

UNVERIFIED PROFILE

Are you Keith S Pentlow?   Register this Author

Register author
Keith S Pentlow

Keith S Pentlow

Publications by authors named "Keith S Pentlow"

Are you Keith S Pentlow?   Register this Author

13Publications

163Reads

27Profile Views

A recommendation for revised dose calibrator measurement procedures for 89Zr and 124I.

PLoS One 2014 9;9(9):e106868. Epub 2014 Sep 9.

Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0106868PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159273PMC
May 2015

Salivary gland side effects commonly develop several weeks after initial radioactive iodine ablation.

J Nucl Med 2009 Oct 16;50(10):1605-10. Epub 2009 Sep 16.

Division of Nuclear Medicine, Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.108.061382DOI Listing
October 2009

The Role of Iodine-124-Positron Emission Tomography Imaging in the Management of Patients with Thyroid Cancer.

PET Clin 2007 Jul 19;2(3):313-20. Epub 2008 Sep 19.

Division of Nuclear Medicine, Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cpet.2008.05.001DOI Listing
July 2007

Prediction of absorbed dose to normal organs in thyroid cancer patients treated with 131I by use of 124I PET and 3-dimensional internal dosimetry software.

J Nucl Med 2007 Jan;48(1):143-9

Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
January 2007

Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software.

J Nucl Med 2004 Aug;45(8):1366-72

Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
August 2004

Quantitative imaging of bromine-76 and yttrium-86 with PET: a method for the removal of spurious activity introduced by cascade gamma rays.

Med Phys 2003 Sep;30(9):2410-23

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1118/1.1595599DOI Listing
September 2003

Coming of age: recombinant human thyroid-stimulating hormone as a preparation for (131)i therapy in thyroid cancer.

J Nucl Med 2003 Jul;44(7):1069-71

Memorial Sloan-Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
July 2003

A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation.

J Nucl Med 2002 Nov;43(11):1482-8

Endocrinology Service, Department of Medicine, Memorial Hospital for Cancer and Allied Diseases, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
November 2002